Trial intelligence / Profile preview

Preoperative Exemestane +/- Tamoxifen in ER+ Breast Cancer

NCT01831076Phase 2Completed

Sponsor
University of Colorado Denver
Start
Apr 2002
Primary completion
Feb 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of exemestane in breast cancer, sponsored by University of Colorado Denver. Started Apr 2002; status: completed.

02

Drugs

exemestane
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT01831076.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01831076.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call